1007-3418
2010 Issue 6
The association between NAT2 polymorphysim and anti-tuberculosis drug-induced hepatitis
WU Yu-mei;LUO Zi-yi;ZHANG Hong-mei;PENG Jing-fu;LIU Sai-yun;WANG Min
WU Yu-mei;LUO Zi-yi;ZHANG Hong-mei;PENG Jing-fu;LIU Sai-yun;WANG Min
..............page:467-469
Effects of astilbin on the expression of TNF a and IL-10 in liver warm ischemia-reperfusion injury
LIN Rong-kai;ZHANG Cheng-hua;MU Ning;YAO Qing-yong;DONG Shao-liang;AI Qiu-bao;WANG Quan-xing
LIN Rong-kai;ZHANG Cheng-hua;MU Ning;YAO Qing-yong;DONG Shao-liang;AI Qiu-bao;WANG Quan-xing
..............page:463-466
The killing effects of cytotoxic T lymphocytes stimulated by specific hAFP-derived peptides on hepatocellular cancer cells
MA Yan-lin;SUN Jian-hai;YAN Fei;LI Li;LIU Li
MA Yan-lin;SUN Jian-hai;YAN Fei;LI Li;LIU Li
..............page:450-454
The relationship of leptin and adiponectin with insulin resistance in nonalcoholic fatty liver disease
LI Yi-ling;YANG Miao;MENG Xiao-dan;HE Xiao-hu;WANG Bing-yuan
LI Yi-ling;YANG Miao;MENG Xiao-dan;HE Xiao-hu;WANG Bing-yuan
..............page:459-462
Detection of HBV resistant mutations related to lamivudine, adefovir and entecavir by reverse hybridization technique
LIU Yan-chen;ZHANG Wen-lu;HU Yuan;ZHAO Li;LAI Guo-qi;HU Jie-li;YANG Feng;HUANG Ai-long
LIU Yan-chen;ZHANG Wen-lu;HU Yuan;ZHAO Li;LAI Guo-qi;HU Jie-li;YANG Feng;HUANG Ai-long
..............page:414-418
Clinical evaluation of liver storage function by indocyanine green retention test
LIU Yi-rong;FAN Zuo-peng;YANG Wei;GAO Yuan;CHEN Yu
LIU Yi-rong;FAN Zuo-peng;YANG Wei;GAO Yuan;CHEN Yu
..............page:476-477
The effect of CCAAT/enhancer-binding protein-alpha overexpression on the metabolism of HepG2 cells
CHEN Yu;LI Wen;LI Wei-hong;ZHANG Hai-yan;DING Mei;REN Feng;AN Wei;DUAN Zhong-ping
CHEN Yu;LI Wen;LI Wei-hong;ZHANG Hai-yan;DING Mei;REN Feng;AN Wei;DUAN Zhong-ping
..............page:474-475
Evolution of hepatitis B virus quasispecies during lamivudine-entecavir sequential therapy
LIU Lin;TANG Ying-zi;LI Jun-gang;ZHOU Ji-jun;WANG Xiao-hong;WANG Yu-ming
LIU Lin;TANG Ying-zi;LI Jun-gang;ZHOU Ji-jun;WANG Xiao-hong;WANG Yu-ming
..............page:423-427
Preventive effect of entecavir on hepatitis B flare up in HBsAg(+) breast cancer patients receiving chemotherapy
DING Pei-pei;HE Gang
DING Pei-pei;HE Gang
..............page:472-473
Responsive prediction in anti-HBV treatment with nucleos(t) ide analogue
DOU Xiao-guang;DING Yang
DOU Xiao-guang;DING Yang
..............page:403-405
..............page:401-402
..............page:402,405,413,449,462,469
The screening and identification of Apolipoprotein A-II from serum differential proteins in hepatocellular carcinoma patients
JIANG Zhi-hua;ZHANG Zhi-yong;HE Min;QIN Jian;WANG Qi;WEI Xiao;NONG Bing-jin;LIU Fei
JIANG Zhi-hua;ZHANG Zhi-yong;HE Min;QIN Jian;WANG Qi;WEI Xiao;NONG Bing-jin;LIU Fei
..............page:445-449
..............page:插页
Some clinical problems of chronic hepatitis B antiviral treatment
GAO Zhi-liang;HUANG Zhan-lian;CHONG Yu-tian;CHEN You-ming
GAO Zhi-liang;HUANG Zhan-lian;CHONG Yu-tian;CHEN You-ming
..............page:406-409
Construction of HCV-producing cell model based on self-cleaving ribozyme
WANG Sheng;AN Xiao-ping;MI Zhi-qiang;LIU Da-bin;ZHANG Bao-zhong;L(U) Jun;ZHOU Yu-sen;TONG Yi-gang
WANG Sheng;AN Xiao-ping;MI Zhi-qiang;LIU Da-bin;ZHANG Bao-zhong;L(U) Jun;ZHOU Yu-sen;TONG Yi-gang
..............page:437-439
Statins in chronic liver diseases: safety and effect
LI Guang-ming;FAN Jian-gao
LI Guang-ming;FAN Jian-gao
..............page:478-480
A pilot study of peginterferon alfa-2a combined with short-term lamivudine therapy in HBeAg-positive chronic hepatitis B patients
HUANG Zhan-lian;ZHAO Zhi-xin;DENG Hong;ZHANG Yu-feng;LU Cui-rong;GAO Zhi-liang
HUANG Zhan-lian;ZHAO Zhi-xin;DENG Hong;ZHANG Yu-feng;LU Cui-rong;GAO Zhi-liang
..............page:419-422
Effects of E-selectin and their legends on the adhesive metastsis of hepatocellular carcinoma
QIAN Shi-kun;CHEN De;LI Yue;YANG Xue-wei;DENG Wu-jian;LI Qiang;LIN Hang;HU Hai;XIAO Jun-qi;CHEN Song-wei
QIAN Shi-kun;CHEN De;LI Yue;YANG Xue-wei;DENG Wu-jian;LI Qiang;LIN Hang;HU Hai;XIAO Jun-qi;CHEN Song-wei
..............page:440-444
Responsive factors and predictors of interferon treatment in patients with chronic hepatitis B
LIU Ya-li;CHEN Xin-yue
LIU Ya-li;CHEN Xin-yue
..............page:410-413
The significance of CD14 and TLR4 expressions in severe hepatitis B induced by endotoxin
CHENG Xiao-yu;ZHANG Lun-li
CHENG Xiao-yu;ZHANG Lun-li
..............page:428-432
Effects of insulin and ly294002 inhibitors of PI3K on the regulations and expression of aquaporin 9 in normal liver cells
LIU Hui;MEI Zhe-chuan;XIAO Xiao
LIU Hui;MEI Zhe-chuan;XIAO Xiao
..............page:455-458
Effects of low frequency magnetic field on the apoptosis of HepG2 cells treated with FeOx nanoparticles
JU Hui-xiang;DAI Zhen-yu;SUN Ming-zhong
JU Hui-xiang;DAI Zhen-yu;SUN Ming-zhong
..............page:470-472
Relationship between liver pathology and clinical characters in HBV carriers
MA Li-na;HE Zhi-min;CAO Zhen-huan;ZHANG Yong-hong;CHEN Xin-yue
MA Li-na;HE Zhi-min;CAO Zhen-huan;ZHANG Yong-hong;CHEN Xin-yue
..............page:433-436